SEC Comment Letter 0000000000-23-006856 to ChromaDex Corp. (CDXC) (CIK 0001386570) (NAGE)
ChromaDex Corp. (CDXC) (CIK 0001386570)
Date: June 27, 2023 · CIK: 0001386570 · Accession: 0000000000-23-006856
AI Filing Summary & Sentiment
File numbers found in text: 333-272828
Letter
United States securities and exchange commission logo June 27, 2023 Robert Fried Chief Executive Officer ChromaDex Corp. 10900 Wilshire Blvd., Suite 600 Los Angeles, CA 90024 Re:ChromaDex Corp. Registration Statement on Form S-3 Filed June 22, 2023 File No. 333-272828 Dear Robert Fried: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jason Drory at 202-551-8342 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Louis Rambo
Show Raw Text
United States securities and exchange commission logo
June 27, 2023
Robert Fried
Chief Executive Officer
ChromaDex Corp.
10900 Wilshire Blvd., Suite 600
Los Angeles, CA 90024
Re:ChromaDex Corp.
Registration Statement on Form S-3
Filed June 22, 2023
File No. 333-272828
Dear Robert Fried:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Jason Drory at 202-551-8342 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Louis Rambo